COVID-19 and the Future of Our Health Research and Innovation System
Life Sciences Ontario, in collaboration with Shift Health, is convening an online session, “COVID-19 and the Future of Our Health Research and Innovation System” on May 28 from 3:00 to 4:30 pm EDT. Speakers include: Dr. Jim Tartaglia, Vice-President R&D, Global Head of Projects, Sanofi Pasteur; Connie Côté, CEO, Health Charites Coalition of Canada; CIHR’s Institute of Infection and Immunity; Bogi Eliasen, Director of Health, Copenhagen Institute for Futures Studies; and Dr. Ryan Wiley, President, Shift Health. More details are available here. To read “COVID-19 and the Future of Health Research and Innovation”, a recent report published by Shift Health, please click here.
Are you a cancer patient, survivor, or caregiver who is interested in learning more about cancer research?
CCRA's Patient Involvement in Cancer Research Program (known as PIP) will be offered this year in a hybrid format. PIP is interwoven into the Canadian Cancer Resear... Read More »
CCRA's Patient Involvement in Cancer Research Program (known as PIP) will be offered this year in a hybrid format. PIP is interwoven into the Canadian Cancer Resear... Read More »
Two Leading Cancer Researchers Appointed as Officers of the Order of Canada
The CCRA congratulates Drs. Anne-Marie Mes-Masson and John Bell, two distinguished cancer researchers and past CCRA awardees, for their appointments as Officers of the Order of Canada in late December 2025.
Anne-Marie Mes-Masson, PhD, FCAHS, FRSC, Associate Scientific Director of ... Read More »
The CCRA congratulates Drs. Anne-Marie Mes-Masson and John Bell, two distinguished cancer researchers and past CCRA awardees, for their appointments as Officers of the Order of Canada in late December 2025.
Anne-Marie Mes-Masson, PhD, FCAHS, FRSC, Associate Scientific Director of ... Read More »